Lanean...
Quantitative benefit-risk assessment of methylprednisolone in multiple sclerosis relapses
BACKGROUND: High-dose short-term methylprednisolone is the recommended treatment in the management of multiple sclerosis relapses, although it has been suggested that lower doses may be equally effective. Also, glucocorticoids are associated with multiple and often dose-dependent adverse effects. Th...
Gorde:
| Argitaratua izan da: | BMC Neurol |
|---|---|
| Egile Nagusiak: | , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
BioMed Central
2015
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4609048/ https://ncbi.nlm.nih.gov/pubmed/26475456 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12883-015-0450-x |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|